1[1]Ring HA.H eller AJ．Farr.In:Revnolds EH.ed Vigabatrin:treatment for chronic epilepsy. J Neurol Neurosurg Psychiatry,1990,53(12):1051-5.
2[2]Bourgeois B.Leppid IE.Sackellares JC.et al.Felbamate:a double blind controlled trial in patients undergoing presurgical evaluation of partial scizures.Neurology,1993,43(4):693-6.
3[3]Sachdeo R.Kraner LD.Rosenberg A.et al.Felbamate monotherapy:controlled trial in patients with partial onset seizures.Am Neurol,1992,32 trolled trial in patients with partial onset seizures.Am Neurol,1992,32(3):386-92.
4[4] Anhut H.Ashman P.Feuerstein TJ.et al.,Gabapentin (Neurontin) as add-on therapy in patients with partial seizures:a double-blind.place-bo-controlled study:the International Gabapentin Study Group.Epilepsia,1994,35(4):795-801.
5[5]Sivenius J.Kalviaimen R.Ylinen A.et al., Double blind study of gabapentin in the treatment of partial seizures.Epilepsia,1991,32(4):539-42.
6[6]UK Gabapenin Study Group NO.5.Gabapentin as add-on therapy in refractory partial eilepsy:a double-blind placebo-controlled.parallel-group study.Neurology,1993,43(11):2292-8.
7[1]McAlindon TE, LaValley MP, Gulin JP, et al. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis[J]. JAMA, 2000, 283(11):1469.
8[2]Anello C. Emerging and recurrent issues in drug development[J]. Stat Med, 1999, 18(17-18) :2301.
9[3]Scholten WK, Halkes SBA. Introducing a system for the assessment of quality, safety, and efficacy of herbal medicinal products in the Netherlands[J]. Drug Inform J,2001, 35:461.
10[4]Sacks HS, Berrier J, Reitman D, et al. Meta-analyses of randomized controlled trials[J]. N Engl J Med, 1987, 316(8) :450.
